Response to Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384

Response to Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384–390

Author:

Bezin Julien¹²^ORCID,Mathieu Clément²,Faillie Jean-Luc³⁴,Pariente Antoine¹²

Affiliation:

1. 1Service de Pharmacologie, Pôle de Santé Publique, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France

2. 2Pharmacoepidemiology Team, UMR 1219 Bordeaux Population Health Research Center, INSERM, University of Bordeaux, Bordeaux, France

3. 3Département de Pharmacologie Médicale et Toxicologie, Centre Hospitalier Universitaire de Montpellier, Montpellier, France

4. 4Desbrest Institute of Epidemiology and Public Health, University of Montpellier, INSERM, Montpellier, France

Funder

Agence Nationale de Sécurité du Médicament et des Produits de Santé

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

Reference9 articles.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献